Villeurbanne, France

Nathalie Bal

This inventor holds 2 USPTO granted patents and 5 published patent applications and 2 EPO patents. Top assignees: Biomerieux Sa, Biomerieux, Inc.. Active years: 2019-2021.

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019-2021

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Nathalie Bal: Innovator in Microbial Detection

Introduction

Nathalie Bal is a prominent inventor based in Villeurbanne, France. She has made significant contributions to the field of microbiology, particularly in the detection of resistant microorganisms. With a total of 2 patents, her work is crucial in advancing medical diagnostics.

Latest Patents

Nathalie Bal's latest patents focus on a medium for the specific detection of resistant microorganisms. This innovative method distinguishes among various groups of Gram-negative bacteria. The first group exhibits a mechanism of resistance to treatment, while the second group, belonging to a different taxon, shows an identical resistance mechanism. Additionally, her work identifies a third group of Gram-negative bacteria that is not resistant to the treatment.

Career Highlights

Throughout her career, Nathalie has worked with notable companies such as bioMérieux SA and bioMérieux, Inc. Her expertise in microbial detection has positioned her as a key player in the industry.

Collaborations

Nathalie has collaborated with several professionals, including Sylvain Orenga and Céline Roger-Dalbert. These partnerships have further enhanced her research and development efforts.

Conclusion

Nathalie Bal's contributions to the detection of resistant microorganisms highlight her innovative spirit and dedication to improving medical diagnostics. Her work continues to impact the field significantly.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…